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Synchronous Ectopic Pancreatoblastoma in a Child: A Case Report 
Pancreatoblastoma is a rare primary pancreatic neoplasm of children that may arise in any 
portion of the pancreas. We report a case of a 3-yr-old boy who presented to with 
abdominal pain our hospital and a progressive bulge in his right abdomen. Biochemical 
evaluation and serum levels of tumoral markers were within reference limits. On the 
computed tomography, two tumors were found. One located in the head of the pancreas; 
however, a laparotomy revealed that the head of pancreas was compressed but normal. 
The other was in the left abdomen near the spleen and the tail of the pancreas. The 
diagnosis of two synchronous pancreatoblastoma originating from the omentum was 
confirmed by pathology. Therefore, a pancreatoblastoma should be considered when a 
large well-defined, lobulated, and heterogeneous mass is identified in the pancreas of 
children. In addition, an ectopic pancreatoblastoma should be considered when identified 
within or near the ectopic pancreatic tissue.
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Pancreatoblastoma is a rare primary pancreatic neoplasm of 
children. It was first described in a 15-month-old boy as “infan-
tile adenocarcinoma of the pancreas” by Becker (1) in 1957. Pan-
creatoblastoma usually affects children between 1-8 yr, although 
rare cases in adults have been reported (2). There is a male pre-
dominance and more than half of the reported cases are in Asians 
(3, 4). The tumor may arise from any portion of the pancreas; 
however, a tumor that originates from ectopic pancreatic tissue 
is extremely rare. To the best of our knowledge, a single case of 
a 4.3-yr-old boy with a tumor originating from ectopic pancre-
atic tissue (mesentery) has been reported by Yang (5), however, 
cases with synchronous ectopic pancreatoblastoma have only 
been reported recently. Although the radiologic features of pan-
creatoblastoma are well described in the literature, few reports 
describe ectopic pancreatoblastoma, particularly about syn-
chronous ectopic pancreatoblastoma. We present a case of a 
3-yr-old boy with ectopic pancreatoblastoma originating from 
the omentum, who has remained disease free more than 1 yr 
after complete tumor resection. 
CASE DESCRIPTION
A 3-yr-old boy presented with abdominal pain was referred to 
our institution for the evaluation of a progressive bulge in his 
right abdomen that his mother had first noticed seven days pre-
vious on February 12, 2009. A biochemical evaluation revealed 
no significant abnormalities. Serum levels of tumoral markers 
(AFP, CA19-9, CA125 and CEA) were within reference limits. A 
physical exam revealed a mildly tender mass in the right hypo-
chondrium extending to the epigastrium; however, two lesions 
were found after a dynamic computed tomography (Fig. 1). The 
primary lesion (8.5 × 4.3 cm) was located in the head of the pan-
creas and partly herniated into the abdominal wall. While the 
secondary lesion (1.8 × 2.1 cm) was in the left abdomen near 
the spleen and the tail of pancreas, and well demarcated from 
the surrounding structures, and no calcifications were evident 
within them (Fig. 1A). They all showed well-defined margins 
and inhomogeneous attenuation due to the presence of cystic 
and solid areas, in the venous phase (Fig. 1C) and the delayed 
phase (Fig. 1D, E), a continuous enhancement was observed 
with a parenchyma density that was higher than that of the arte-
rial phase. In addition, a large and distorted vascular shadow 
(Fig. 1B) inside of the tumors in the arterial phase in the prima-
ry lesion. There was no radiological evidence of nodal or distant 
metastases; however, there was a local infiltration of the adja-
cent abdominal muscle that required a laparotomy.
  Surgery revealed the primary lesion was firmly adhered to the 
adjacent omental and abdominal muscle; in addition, a local 
infiltration of the liver and stomach were also noted. The head 
of the pancreas was compressed and could be separated from 
the tumor due to well-defined margins. The bile duct, portal 
vein, and the inferior vena cava were also compressed but pat-
ent. The gross specimen showed a resected mass measuring 8 × 
4 × 4 cm that was well circumscribed and solid with areas of ne-Yang Z-H, et al.  •  Synchronous Ectopic Pancreatoblastoma in a Child
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crosis and hemorrhaging. No calcifications were evident within 
the mass. The secondary lesion was also adhered to the adjacent 
omentum and spleen; however, it was well demarcated from 
the surrounding structures with no evidence of originating from 
the pancreas. A histopathological analysis revealed a resected 
mass measuring 3 × 4 × 3 cm, which was well encapsulated by 
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Fig. 1. CT findings of the pancreatoblastoma in a 3-yr-old boy. On non-contrast CT (A) two tumors were noticed, the primary lesion (black arrow) located in the head of the 
pancreas, and partly herniated into the abdominal wall. While the secondary lesion (white arrow) is in the left abdomen near the spleen and the tail of pancreas, and well 
demarcated from the surrounding structures. They all showed inhomogeneous attenuation and no calcifications were evident within the mass. On dynamic CT scanning (B) 
arterial phase; (C) portal phase; (D, E) delayed phase. The tumors were inhomogenously enhanced, in the venous phase and delayed phase. A continuous enhancement was 
observed with the parenchyma density higher than that of arterial phase. In addition, a large and distorted vascular shadow (arrow) inside the tumors in arterial phase was in 
the primary lesion. Although the head of pancreas was firmly replaced with well-defined margins, the dilatation of the intrahepatic biliary tree and main pancreatic duct were 
not visible. Portal vein and the inferior vena cava were also compressed but patent. Five months after a complete tumors resection, a transverse CT image (F) demonstrates a 
normal pancreas (arrow), which is homogeneous and slightly hypodense relative to the liver. Moreover, there was no radiological evidence of nodal or liver metastases. 
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Fig. 2. Photomicrograph of the resected 
pancreatoblastoma. (A, B) The original 
tumor was mainly composed of neoplastic 
cells in acini-like structures (original mag-
nification; H&E stain, × 100 and × 200 
respectively). (C, D) A typical pancreato-
blastoma of the secondary lesion (original 
magnification; H&E stain, × 100 and × 200 
respectively) demon  strates an epithelial 
tumor with acinar formation, similar with 
the primary lesion.Yang Z-H, et al.  •  Synchronous Ectopic Pancreatoblastoma in a Child
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omentum with no calcifications within the mass. The surgical 
resection was difficult due to the extensive nature of the tumor, 
but the two lesions were completely resected without the pan-
creas being damaged. In the final pathology report following 
surgery, the diagnosis of pancreatoblastoma was confirmed 
with histopathological results, and the secondary lesion histol-
ogy and immunohistochemistry was consistent with the find-
ings of the primary lesion (Fig. 2).
  After surgery, the patient was treated with adjuvant chemo-
therapy (vincristine, cyclophosphamide, and epirubicin) regu-
larly. At the time of this report, 18 months after complete tumor 
resection, the patient is currently in good condition and without 
radiological evidence of recurrent tumor or metastases (Fig. 1F) 
with normal levels of CA 125, CA 19-9 and AFP to date.
DISCUSSION
Ectopic pancreas, which is also known as heterotopic or aber-
rant pancreas, describes pancreatic tissue in an aberrant loca-
tion without vascular or ductal connection to the orthotopic 
pancreas (6). Ectopic pancreas is a relatively frequent congeni-
tal anomaly and the reported incidence ranges from 2% to 15% 
(7); however, the true incidence is unknown as most patients are 
asymptomatic and the condition is usually an incidental find-
ing during autopsy or laparotomy. The most frequent sites are 
the gastric antrum (30%), duodenum (30%), and jejunum (20%) 
(7). On occasion, an ectopic pancreas has been found in the il-
eum, colon, spleen, liver, umbilicus, biliary tract, omentum, mes-
entery, mediastinum and Meckel’s diverticulum (8, 9). Ectopic 
pancreas occurs in all ages and the male-to-female ratio is ap-
proximately 2:1. The histogenesis of this lesion is still unclear. 
Ectopic pancreas undergoes changes similar to the native pan-
creatic gland and symptoms often depend upon location. Chang-
es to the ectopic tissue can include acute or chronic pancreati-
tis, fibrosis, and even the development of pancreatic adenocar-
cinoma (10, 11). 
  Pancreatoblastoma accounts for 0.5% of exocrine tumors of 
the pancreas and the highest incidence is found in the first de-
cade of life with a predilection for males and Asians (3, 4). Pan-
creatoblastoma may arise in any portion of the pancreas. Pancre-
atoblastoma originating from the ectopic pancreas is extremely 
rare, a single case of a 4.3-yr-old boy with a tumor originating 
from ectopic pancreatic tissue (mesentery) has been reported 
so far (5). In our study, we found a 3-yr-old boy with two syn-
chronous pancreatoblastoma in the abdomen. A laparotomy 
revealed that the head of pancreas was compressed but normal. 
Serial postoperative radiological examinations also revealed no 
mass in the pancreas. In the final pathology report following sur-
gery, the diagnosis of pancreatoblastoma was confirmed, and 
the secondary lesion histology and immunohistochemistry was 
consistent with the findings of the primary lesion. Guillou et al. 
(12) described 3 conditions necessary to prove that a malignan-
cy arose from ectopic pancreas: 1) the tumor must be within or 
near the ectopic pancreatic tissue, 2) a direct transition between 
pancreatic structures and carcinoma must be observed, and 3) 
the non-neoplastic pancreatic tissue must at a minimum com-
prise fully developed acini and ductal structures. Our case satis-
fied all 3 conditions. Therefore, we believe that the two synchro-
nous tumors may originate from ectopic pancreatic tissue in 
the omentum there has been unreported in previous studies. It 
supported the view that the pancreatoblastoma was embryonic 
in origin and hamartomatous in the early stages of the embryo.
  The pathologic features of pancreatoblastoma are well de-
scribed in the literature, but few series describe the radiologic 
features of pancreatoblastoma. The radiological features are usu-
ally those of well-defined, lobulated, heterogeneous masses, 
with necrosis and/or calcification, usually arising from the body 
and/or tail of the pancreas or involving the entire organ, rather 
than being universally located in the pancreatic head (13). The 
mass is often so large at presentation as to make determination 
of the organ of origin quite difficult. In the series of Montema-
rano et al. (14), in only half of the cases did the imaging appear-
ance suggest the pancreas as the organ of origin. These large tu-
mors typically compress the surrounding structures without ap-
pearing to invade them, although local invasion may be evident 
at surgical resection (14, 15). In our case, the two tumors were 
all heterogeneous and well-defined; in addition, calcification 
were not seen within them. In the arterial phase, a moderate en-
hancement was observed in parenchyma, while in the venous 
phase and delayed phase, continuous enhancement was ob-
served with a parenchyma density higher than that of the arte-
rial phase. In addition, a large and distorted vascular shadow 
inside the tumors in the arterial phase was in the primary lesion. 
Despite the fact that CT findings suggest an encapsulated tumor, 
the local infiltration of the liver and stomach were also noted at 
surgical resection.
  Although there are certain characteristic imaging findings, 
the diagnosis of pancreatoblastoma relies mainly on pathology. 
The presenting features of pancreatoblastoma are commonly 
nonspecific and referable to the presence of an upper abdomi-
nal mass. Since pancreatoblastomas are of a soft and gelatinous 
consistency, they rarely cause biliary or duodenal obstruction, 
but they may encase adjacent vessels. More than 15% of patients 
with pancreatoblastoma present with metastases at the time of 
diagnosis and additional patients develop metastases later in 
the course of the disease (4). The liver is the most common site 
of metastases; however, regional lymph nodes, peritoneal, bone, 
pulmonary, and mediastinal metastases have also been de-
scribed (16, 17). Vascular invasion is uncommon and ascites 
may be an indicator of tumor spread (14). According to the bio-
logical growth characteristics of pancreatoblastoma and to the 
literature review, complete surgical resection remains the treat-Yang Z-H, et al.  •  Synchronous Ectopic Pancreatoblastoma in a Child
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ment most commonly associated with a good prognosis and no 
late complications. Unresectable or recurrent disease was shown 
to respond to chemotherapy. The production of alpha-fetopro-
tein (AFP) by pancreatoblastoma has been noted repeatedly in 
the literature, both in the form of serum elevation and immu-
nohistochemical detection. AFP may be useful for diagnosis 
and used as a tumor marker in follow-up after surgery and dur-
ing chemotherapy (18). It also should be noted that the value of 
serum AFP is limited in neonates, because a higher level of se-
rum AFP may be normal. Our patient had two localized tumors 
that were completely resected and the child is currently doing 
well and 1.5 yr disease-free at follow-up. Preoperative and post-
operative serum levels of tumoral markers (AFP, CA19-9, CA125 
and CEA) were within reference limits.
  In conclusion, pancreatoblastoma is a rare primary tumor of 
the pancreas and ectopic pancreatoblastoma is even rarer. When 
a large well-defined, lobulated, heterogeneous mass, with ne-
crosis and/or calcification is identified in the pancreas of chil-
dren, the diagnosis of pancreatoblastoma should be considered. 
Furthermore, an ectopic pancreatoblastoma should be includ-
ed in the differential diagnosis when identified within or near 
the ectopic pancreatic tissue. As the present case shows, this tu-
mor can also occur synchronously outside the orthotopic pan-
creas: synchronous ectopic pancreatoblastoma. We report on 
this rare disease to emphasize its clinical features, radiological 
findings, laboratory findings, diagnosis, and management. To 
our knowledge, synchronous ectopic pancreatoblastoma was 
reported for the first time.
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